Starling Oncology, Inc. (STLN) Stock buybacks 2021–2024
Starling Oncology, Inc. (STLN) annual stock buyback history — cash paid to repurchase common stock, per SEC filings.
$0FY2024 · since FY2021: $0 → $0
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | $0 | -100.0% |
| FY2023 | $1.0M | -88.7% |
| FY2022 | $9.0M | — |
| FY2021 | $0 | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More STLN financial trends
STLN RevenueSTLN Net incomeSTLN Net marginSTLN Gross profitSTLN Gross marginSTLN Operating incomeSTLN Operating marginSTLN Operating cash flowSTLN Free cash flowSTLN Capital expendituresSTLN Return on equitySTLN Dividends paidSTLN Total assetsSTLN Total liabilitiesSTLN Shareholders’ equitySTLN overview →